
### [Orphanet:68362](http://www.orpha.net/ORDO/Orphanet_68362)
**Label:** Rare vascular disease

**Subclasses:** [Orphanet:458718](http://www.orpha.net/ORDO/Orphanet_458718) (Idiopathic spontaneous coronary artery dissection), [Orphanet:820](http://www.orpha.net/ORDO/Orphanet_820) (Sneddon syndrome), [Orphanet:1682](http://www.orpha.net/ORDO/Orphanet_1682) (Arterial dissection-lentiginosis syndrome), 

**Corr. equiv. classes:** [Orphanet:1682](http://www.orpha.net/ORDO/Orphanet_1682), [Orphanet:458718](http://www.orpha.net/ORDO/Orphanet_458718), [OMIM:600459](http://purl.obolibrary.org/obo/OMIM_600459), [OMIM:182410](http://purl.obolibrary.org/obo/OMIM_182410), [OMIM:122455](http://purl.obolibrary.org/obo/OMIM_122455), [Orphanet:820](http://www.orpha.net/ORDO/Orphanet_820), 

**Class expressions from DL-Learner:**

- [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 66.67%
- [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 66.67%
- [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 66.67%
- [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 66.67%
- [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) 66.67%
- [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 66.67%
- [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) and [HP:0010549](http://purl.obolibrary.org/obo/HP_0010549) (Weakness due to upper motor neuron dysfunction) 66.67%
- [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) and [HP:0004374](http://purl.obolibrary.org/obo/HP_0004374) (Hemiplegia/hemiparesis) 66.67%
- [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) and [HP:0004305](http://purl.obolibrary.org/obo/HP_0004305) (Involuntary movements) 66.67%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) 66.67%
- [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) 66.67%
- [HP:0002315](http://purl.obolibrary.org/obo/HP_0002315) (Headache) and [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) 66.67%
- [HP:0002167](http://purl.obolibrary.org/obo/HP_0002167) (Neurological speech impairment) and [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) 66.67%
- [HP:0001337](http://purl.obolibrary.org/obo/HP_0001337) (Tremor) and [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) 66.67%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003613](http://purl.obolibrary.org/obo/HP_0003613) (Antiphospholipid antibody positivity) 66.67%


